REDHILL BIOPHARMA LTD. Foreign Exchange Loss
REDHILL BIOPHARMA LTD. (RDHL) reported Foreign Exchange Loss of $31.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2025-04-10
| Period end | Foreign Exchange Loss 12 month |
|---|---|
| 2024-12-31 | $31.00K 20-F · filed 2025-04-10 |
| 2023-12-31 | $115.00K 20-F · filed 2025-04-10 |
| 2022-12-31 | $40.00K 20-F · filed 2025-04-10 |